Blueberry for Fatty Liver: Evidence and Advice

Blueberry for fatty liver is a topic attracting growing scientific interest, as these antioxidant-rich fruits contain anthocyanins that may support liver health. Fatty liver disease, now more commonly termed metabolic dysfunction-associated steatotic liver disease (MASLD), affects a significant proportion of UK adults and is closely linked to obesity, type 2 diabetes, and insulin resistance. While laboratory and animal studies suggest blueberries may help reduce liver inflammation and fat accumulation, the evidence in humans remains preliminary. This article explains what the research shows, how much to eat, and what else you can do to support your liver.

Can eating blueberries really help with a fatty liver?

Blueberries may offer modest support for liver health through their anthocyanin content, but they are not a recognised treatment for fatty liver disease and should not replace medical advice or lifestyle changes.

Blueberries may offer modest support for liver health, but they are not a treatment for fatty liver disease and should not replace medical advice or lifestyle changes recommended by a clinician.

Fatty liver disease most commonly arises from metabolic risk factors such as obesity, type 2 diabetes, high cholesterol, and insulin resistance. This form is known as metabolic dysfunction-associated steatotic liver disease (MASLD), which replaces the older term non-alcoholic fatty liver disease (NAFLD) in international nomenclature. UK clinical guidance, including NICE guideline NG49, still uses the term NAFLD, so you may see both terms used.^[1][2] Alcohol-related liver disease (ALD) is a separate condition caused by harmful alcohol use, though some individuals have features of both (sometimes called MetALD). The lifestyle advice in this article relates primarily to metabolic fatty liver disease (MASLD/NAFLD).

Blueberries are rich in a group of plant compounds called anthocyanins, which give them their deep blue-purple colour. These compounds have antioxidant and anti-inflammatory properties that have attracted scientific interest in the context of liver health. Laboratory and animal studies suggest anthocyanins may help reduce oxidative stress and inflammation in liver tissue, both of which play a role in the progression of fatty liver disease.

However, blueberries are a dietary food, not a medicine. No regulatory body such as the MHRA or NICE has evaluated or recommended blueberries as a treatment for any liver condition. Eating blueberries as part of a balanced, varied diet is a sensible and safe choice, but expecting them to reverse fatty liver disease on their own would be unrealistic. They are best understood as one potentially helpful component of a broader dietary pattern, such as a Mediterranean-style diet, which has a stronger evidence base for liver health than any single food.

What does the evidence say about blueberries and liver health?

Current evidence is promising but preliminary, with most robust findings from animal studies and small human trials; neither NICE nor the NHS recommends blueberries as part of any clinical pathway for fatty liver disease.

The current evidence on blueberries and liver health is promising but largely preliminary, with the most robust findings coming from animal studies and small human trials rather than large, well-controlled clinical trials.

Several animal studies have shown that blueberry extract or anthocyanin supplementation can reduce liver fat accumulation, lower markers of liver inflammation, and improve insulin sensitivity in rodent models of fatty liver disease.^[19][18] These findings have generated genuine scientific interest.

In human research, a small number of controlled studies have examined the effects of blueberry consumption on liver enzymes and metabolic markers. Some have reported modest reductions in alanine aminotransferase (ALT), a liver enzyme that rises when liver cells are damaged, following regular blueberry intake. However, these studies have generally involved small participant numbers, short durations, and varying doses (often using concentrated or freeze-dried preparations rather than whole fruit), making it difficult to draw firm conclusions about the effect of eating blueberries in normal dietary quantities.

A 2019 review published in the journal Nutrients examined the role of anthocyanins in NAFLD and concluded that while the mechanistic evidence was encouraging, high-quality randomised controlled trials in humans were still needed. The evidence base has not substantially changed since then: the NHS and NICE do not currently recommend blueberries or anthocyanin supplements as part of any clinical pathway for fatty liver disease.

Patients should therefore view blueberries as a nutritious addition to their diet rather than a therapeutic intervention. For authoritative patient-facing information, the NHS website and the British Liver Trust both provide guidance on NAFLD and MASLD.

How do blueberries affect fat build-up in the liver?

Anthocyanins in blueberries may reduce oxidative stress, modulate fat metabolism enzymes, and improve insulin sensitivity, but most supporting evidence comes from laboratory or animal studies rather than human trials.

Blueberries may influence fat accumulation in the liver through several biological mechanisms, primarily driven by their anthocyanin content. Anthocyanins are a type of flavonoid that act as antioxidants, neutralising reactive oxygen species (free radicals) that can damage liver cells and promote inflammation. Chronic low-grade inflammation is a key driver of the progression from simple liver fat accumulation (steatosis) to more serious conditions such as metabolic dysfunction-associated steatohepatitis (MASH), previously called non-alcoholic steatohepatitis (NASH).

Research in animal models suggests anthocyanins may also influence lipid metabolism by modulating enzymes involved in fat synthesis and breakdown within the liver, including reducing the activity of fatty acid synthase, an enzyme that promotes fat production, while enhancing fat oxidation pathways. Some studies also suggest blueberries may improve insulin sensitivity, which is relevant because insulin resistance is a central driver of fat accumulation in the liver.

Blueberries also contain dietary fibre, vitamin C, and other polyphenols that contribute to overall metabolic health. Fibre supports gut microbiome diversity, and emerging research suggests the gut-liver axis plays an important role in fatty liver disease: a healthier gut microbiome may reduce the amount of inflammatory signals reaching the liver via the portal circulation.^[13][14]

While these mechanisms are biologically plausible, it is important to emphasise that most of this evidence comes from laboratory or animal settings. The extent to which these effects translate meaningfully to humans eating normal dietary quantities of blueberries remains an open question, and no clinical recommendations follow from this preclinical data alone.

How many blueberries should you eat if you have fatty liver disease?

No UK guideline sets a specific daily target; including roughly 80 grams as one of your five-a-day portions is a practical goal, with a registered dietitian able to provide personalised advice.

There is no officially recommended daily amount of blueberries specifically for fatty liver disease, as no UK clinical guideline from NICE or the NHS sets a target for this purpose. Some human studies that have examined effects on liver markers have used amounts in the range of 150 to 300 grams per day, but these figures come from research settings, often using concentrated or freeze-dried preparations, and should not be interpreted as a clinical prescription or a target for everyday eating.

For general health, the NHS recommends eating at least five portions of fruit and vegetables per day, with one portion of fruit equating to roughly 80 grams.^[5][6] A generous handful of blueberries, approximately 80 grams, counts as one of your five a day. Including blueberries regularly within this framework is a practical and achievable goal for most people.

Blueberries, like all fruit, contain natural sugars. For people with fatty liver disease who also have type 2 diabetes or insulin resistance, overall carbohydrate and sugar intake should be considered as part of a broader dietary plan. Eating blueberries as part of a meal rather than alone, and pairing them with protein or healthy fats, may help moderate any effect on blood glucose. Diabetes UK provides guidance on fruit and glycaemic management for people with diabetes.

Fresh and frozen blueberries generally retain their anthocyanin content well. Freezing and thawing tends to preserve anthocyanins better than many drying or juicing processes, and the anthocyanin content of dried blueberries can vary considerably depending on the drying method used. Blueberry juices and sweetened products are generally less beneficial due to their higher sugar content and lower fibre levels; if buying dried blueberries, check the label to avoid products with added sugars. A registered dietitian can provide personalised dietary guidance for people managing fatty liver disease.

What else can you do alongside diet changes to support your liver?

NICE guideline NG49 supports weight loss, a Mediterranean-style diet, regular physical activity, and alcohol reduction as the most effective lifestyle interventions for metabolic fatty liver disease.

Diet changes, including incorporating blueberries, are most effective when combined with broader lifestyle modifications that address the underlying causes of fatty liver disease. NICE guideline NG49 (Non-alcoholic fatty liver disease: assessment and management) emphasises that weight loss is one of the most effective interventions for reducing liver fat, with a loss of around 7 to 10 percent of body weight associated with meaningful improvements in liver histology in people with excess weight.^[1][2]

The following lifestyle measures are supported by clinical evidence and NHS guidance:

• Physical activity: Regular aerobic exercise and resistance training can reduce liver fat independently of weight loss. NHS guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults.^[7]

• Dietary pattern: A Mediterranean-style diet, rich in vegetables, legumes, whole grains, oily fish, olive oil and nuts, has the strongest dietary evidence for improving liver health and metabolic markers, as reflected in EASL guidance and British Liver Trust recommendations.^[9][10]

• Alcohol reduction: Harmful alcohol use causes a separate form of liver disease (ALD), but even in metabolic fatty liver disease, keeping alcohol within the UK Chief Medical Officers' low-risk guidelines (no more than 14 units per week, spread across three or more days, with several alcohol-free days) is advisable, as alcohol places additional strain on the liver.^[8]

• Blood sugar and cholesterol management: Controlling type 2 diabetes and dyslipidaemia through medication and lifestyle reduces the metabolic burden on the liver.

• Avoiding hepatotoxic substances: Some supplements and herbal remedies can harm the liver. Always inform your GP before taking any new supplement. If you suspect you have experienced an adverse reaction to a medicine, vaccine, or herbal supplement, you can report this via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

For people exploring structured weight management support, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be considered alongside lifestyle advice.

When should you see a GP about fatty liver disease?

See your GP if you have known fatty liver disease, relevant risk factors, or symptoms such as fatigue, right-sided abdominal discomfort, or jaundice; urgent symptoms like vomiting blood require immediate assessment.

You should see your GP if you have been told you have fatty liver disease, if you are at risk due to obesity, type 2 diabetes or high cholesterol, or if you experience symptoms that may suggest liver problems. Fatty liver disease is often silent in its early stages and is frequently detected incidentally during blood tests or an abdominal ultrasound carried out for another reason.

Symptoms that warrant a GP appointment include:

• Persistent fatigue or low energy that has no obvious explanation

• Discomfort or a dull ache in the upper right side of the abdomen

• Unexplained weight loss

• Yellowing of the skin or whites of the eyes (jaundice)

• Swelling of the abdomen or legs

• Vomiting blood or passing black, tarry stools

Jaundice, significant abdominal swelling, confusion alongside liver symptoms, or vomiting blood should prompt urgent assessment. Contact NHS 111 for urgent advice if you are unsure whether your symptoms need same-day attention, or go to your nearest accident and emergency department if you believe the situation is life-threatening.

Your GP can arrange blood tests to check liver enzymes such as ALT and AST. In line with NICE guideline NG49, the first step in assessing the degree of liver scarring (fibrosis) in primary care is usually a non-invasive risk score such as the FIB-4 index or the NAFLD Fibrosis Score, calculated from routine blood results.^[1][2] Depending on the result, your GP may refer you for further assessment, which can include an enhanced liver fibrosis (ELF) blood test or transient elastography (sometimes called a FibroScan), which measures liver stiffness as a marker of fibrosis. An abdominal ultrasound is useful for detecting the presence of liver fat (steatosis) but is not reliable for staging fibrosis. Availability of these tests may vary by local integrated care board (ICB) pathway.

Early identification and management can prevent progression to cirrhosis or liver failure. Dietary changes such as eating blueberries are a positive step, but they do not replace clinical assessment and should be discussed with your GP as part of an overall management plan. The British Liver Trust website provides further patient-facing information on NAFLD and MASLD assessment.

Scientific References

1. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49).
2. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49) – full guideline PDF.
3. Non-alcoholic fatty liver disease (NAFLD): assessment and management (NG49) – short version of draft guideline.
4. AGA Clinical Practice Update on the Evaluation and Management of Metabolic Dysfunction- and Alcohol-Associated Liver Disease: Expert Review. Clinical Gastroenterology and Hepatology..
5. 5 A Day: what counts?.
6. 5 A Day portion sizes.
7. Physical activity guidelines for adults aged 19 to 64.
8. Alcohol consumption: advice on low risk drinking.
9. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease. Journal of Hepatology..
10. Adherence to a Mediterranean diet may improve serum adiponectin in adults with nonalcoholic fatty liver disease: The MEDINA randomized controlled trial. Nutrition Research..
11. Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes: The DIRECT PLUS clinical trial. Hepatology..
12. Adherence to a "MediterrAsian" diet is associated with weight loss-independent improvements in liver fat and lipid profile. Frontiers in Nutrition..
13. The gut-liver axis: microbial mechanisms and therapeutic implications in MAFLD. Frontiers in Cellular and Infection Microbiology..
14. Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease Progression. Critical Reviews in Oncogenesis..
15. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota. Cancer Science..
16. Malvidin-3-glucoside and related anthocyanins modulate hepatic lipid metabolism. Journal of Agricultural and Food Chemistry..
17. Polyphenols from blue honeysuckle berry inhibit lipid accumulation in adipocytes by suppressing lipogenesis. Journal of Ethnopharmacology..
18. Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation. PLoS One..
19. Protective effects of blueberries (Vaccinium corymbosum L.) extract against cadmium-induced hepatotoxicity in mice. Environmental Toxicology and Pharmacology..
20. Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study. Nature Medicine..
21. Performance of fibrosis-4 and NAFLD fibrosis score for screening liver fibrosis in Indian individuals with type 2 diabetes. Diabetes & Metabolic Syndrome..

Frequently Asked Questions